{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T10:48:27Z","timestamp":1770461307143,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Information about prevalence and associated factors of non-alcoholic fatty liver disease (NAFLD) has been scarce for the Russian, Eastern European and Central Asian world region. We assessed prevalence and associated factors of NAFLD in two population-based studies (Ural Eye and Medical Study (UEMS), Ural Very Old Study (UVOS)), which were conducted in rural and urban regions in Bashkortostan\/Russia and included participants aged 40\u2009+\u2009years and 85\u2009+\u2009years, respectively. Defining NAFLD by an absence of regular alcohol consumption, and by abnormally high alanine transaminase (ALT) and aspartate transaminase (AST) concentrations or an AST\/ALT ratio of\u2009&gt;\u20091.0, 2341 out of 5852 UEMS participants (40.0%; 95% confidence intervals (CI) 38.8, 41.3) had NAFLD. A higher NAFLD prevalence correlated (multivariable analysis) with older age (odds ratio (OR) 1.02; 95%CI 1.01, 1.03; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), female sex (OR 1.87; 95%CI 1.58, 2.21; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), higher waist-hip circumference ratio (OR 2.64; 95%CI 1.11, 6.27; <jats:italic>P<\/jats:italic>\u2009=\u20090.03), lower depression score (OR 0.98; 95%CI 0.96, 0.999; <jats:italic>P<\/jats:italic>\u2009=\u20090.04), higher serum concentrations of creatinine (OR 1.004; 95%CI 1.000, 1.008; <jats:italic>P<\/jats:italic>\u2009=\u20090.03) and bilirubine (OR 1.009; 95%CI 1.002, 1.015; <jats:italic>P<\/jats:italic>\u2009=\u20090.008), lower prothrombin index (OR 0.99; 95%CI 0.985, 0.998; <jats:italic>P<\/jats:italic>\u2009=\u20090.01), lower ankle-brachial index (OR 0.49; 95%CI 0.32, 0.75; <jats:italic>P<\/jats:italic>\u2009=\u20090.001), higher prevalence of a grain-rich diet (OR 1.88; 95%CI 1.50, 2.36; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and iron deficiency-related anemia (OR 1.61; 95%CI 1.13, 2.29; <jats:italic>P<\/jats:italic>\u2009=\u20090.009), and lower prevalence of vigorous leisure activities (OR 0.84; 95%CI 0.72, 0.99; <jats:italic>P<\/jats:italic>\u2009=\u20090.04). In the UVOS, NAFLD prevalence (mean: 789\/1130; 69.8%; 95%CI 67.1, 72.3) was associated with female sex (OR 2.24; 95%CI 1.66, 3.01; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), higher serum concentrations of low-density lipoproteins (OR 1.34; 95%CI 1.17, 1.55; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), lower prothrombin index (OR 0.98; 95%CI 0.96, 0.99; <jats:italic>P<\/jats:italic>\u2009=\u20090.002), and lower ankle-brachial index (OR 0.03; 95%CI 0.02, 0.29; <jats:italic>P<\/jats:italic>\u2009=\u20090.003). The NAFLD prevalence of 40% in the UEMS and 69.8% in the UVOS corresponds to findings obtained in other world regions and shows the importance of NAFLD, including its determinants such as age, sex, waist-hip ratio, serum creatinine concentration, prothrombin index, ankle-brachial index, and lower physical activity.<\/jats:p>","DOI":"10.1038\/s41598-022-12004-y","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T11:03:10Z","timestamp":1652353390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of non-alcoholic fatty liver disease in the Russian Ural Eye and Medical Study and the Ural Very Old Study"],"prefix":"10.1038","volume":"12","author":[{"given":"Mukharram M.","family":"Bikbov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timur R.","family":"Gilmanshin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinat M.","family":"Zainullin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyulli M.","family":"Kazakbaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellina M.","family":"Iakupova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albina A.","family":"Fakhretdinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azaliia M.","family":"Tuliakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songhomitra","family":"Panda-Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leisan I.","family":"Gilemzianova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinar A.","family":"Khakimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana A.","family":"Miniazeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"12004_CR1","doi-asserted-by":"crossref","unstructured":"Eslam, M., Sanyal, A.J., George, J. & International consensus Panel. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158, 1999\u20132014.e1 (2020).","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"12004_CR2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong, M. J., Adams, L. A., Canbay, A. & Syn, W. K. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59, 1174\u20131197 (2014).","journal-title":"Hepatology"},{"key":"12004_CR3","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella, M. E. Nonalcoholic fatty liver disease: A systematic review. JAMA 313, 2263\u20132273 (2015).","journal-title":"JAMA"},{"key":"12004_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67, 328\u2013357 (2018).","journal-title":"Hepatology"},{"key":"12004_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"12004_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"12004_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","volume":"16","author":"NE Rich","year":"2018","unstructured":"Rich, N. E. et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: A systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 16, 198-210.e2 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"12004_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003100","volume":"17","author":"H Jarvis","year":"2020","unstructured":"Jarvis, H. et al. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. PLoS Med. 17, e1003100 (2020).","journal-title":"PLoS Med."},{"key":"12004_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"Musso, G. et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: A systematic review and meta-analysis. PLoS Med. 11, e1001680 (2014).","journal-title":"PLoS Med."},{"key":"12004_CR10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1161\/HYPERTENSIONAHA.120.15220","volume":"76","author":"S Ciardullo","year":"2020","unstructured":"Ciardullo, S. et al. Nonalcoholic fatty liver disease and advanced fibrosis in US adults across blood pressure categories. Hypertension 76, 562\u2013568 (2020).","journal-title":"Hypertension"},{"key":"12004_CR11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/liv.14828","volume":"41","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo, S. & Perseghin, G. Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver Int. 41, 1290\u20131293 (2021).","journal-title":"Liver Int."},{"key":"12004_CR12","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi, Z. et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69, 2672\u20132682 (2019).","journal-title":"Hepatology"},{"key":"12004_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.5152\/tjg.2019.18045","volume":"30","author":"E Kaya","year":"2019","unstructured":"Kaya, E. & Y\u0131lmaz, Y. Non-alcoholic fatty liver disease: A growing public health problem in Turkey. Turk J Gastroenterol. 30, 865\u2013871 (2019).","journal-title":"Turk J Gastroenterol."},{"key":"12004_CR14","first-page":"37","volume":"2","author":"Y Yilmaz","year":"2021","unstructured":"Yilmaz, Y. et al. The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study. Hepatology Forum. 2, 37\u201342 (2021).","journal-title":"Hepatology Forum."},{"key":"12004_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S. & Neuschwandet-Tetri, B. A. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57, 1441\u20131447 (2008).","journal-title":"Gut"},{"key":"12004_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1741-7015-7-21","volume":"7","author":"V Nobili","year":"2009","unstructured":"Nobili, V. et al. The pediatric NAFLD fibrosis index: A predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med. 7, 21 (2009).","journal-title":"BMC Med."},{"key":"12004_CR17","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson, S., Stewart, S. F., Henderson, E., Burt, A. D. & Day, C. P. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 59, 1265\u20131269 (2010).","journal-title":"Gut"},{"key":"12004_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.0567","volume":"3","author":"MM Bikbov","year":"2020","unstructured":"Bikbov, M. M. et al. Prevalence of myopic maculopathy among adults in a Russian population. JAMA Netw. Open 3, e200567 (2020).","journal-title":"JAMA Netw. Open"},{"key":"12004_CR19","doi-asserted-by":"publisher","first-page":"7483","DOI":"10.1038\/s41598-018-25928-1","volume":"8","author":"MM Bikbov","year":"2018","unstructured":"Bikbov, M. M. et al. Frequency and associated factors of bone fractures in Russians: The Ural Eye and Medical Study. Sci. Rep. 8, 7483 (2018).","journal-title":"Sci. Rep."},{"key":"12004_CR20","unstructured":"Federal State Statistic Service. Population Census. https:\/\/eng.gks.ru\/folder\/76215; Retrieved 11.12.2021."},{"key":"12004_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.21138","volume":"4","author":"MM Bikbov","year":"2021","unstructured":"Bikbov, M. M. et al. Prevalence factors associated with vision impairment and blindness among individuals 85 years and older in Russia. JAMA Netw. Open 4, e2121138 (2021).","journal-title":"JAMA Netw. Open"},{"key":"12004_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2190\/FUFR-PK9F-6U10-JXRK","volume":"31","author":"JL Thomas","year":"2001","unstructured":"Thomas, J. L., Jones, G. N., Scarinci, I. C., Mehan, D. J. & Brantley, P. J. The utility of the CES-D as a depression screening measure among low-income women attending primary care clinics. The Center for Epidemiologic Studies-Depression. Int. J. Psychiatry Med. 31, 25\u201340 (2001).","journal-title":"Int. J. Psychiatry Med."},{"key":"12004_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"key":"12004_CR24","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens, G. A. et al. Guidelines for accurate and transparent health estimates reporting: The GATHER statement. Lancet 388, e19\u2013e23 (2016).","journal-title":"Lancet"},{"key":"12004_CR25","doi-asserted-by":"publisher","first-page":"l5367","DOI":"10.1136\/bmj.l5367","volume":"367","author":"M Alexander","year":"2019","unstructured":"Alexander, M. et al. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: Findings from matched cohort study of 18 million European adults. BMJ 367, l5367 (2019).","journal-title":"BMJ"},{"key":"12004_CR26","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jhep.2012.07.028","volume":"57","author":"EM Koehler","year":"2012","unstructured":"Koehler, E. M. et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study. J. Hepatol. 57, 1305\u20131311 (2012).","journal-title":"J. Hepatol."},{"key":"12004_CR27","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter, T. G. & Rinella, M. Nonalcoholic fatty liver disease 2020: The state of the disease. Gastroenterology 158, 1851\u20131864 (2020).","journal-title":"Gastroenterology"},{"key":"12004_CR28","first-page":"31","volume":"25","author":"VT Ivashkin","year":"2015","unstructured":"Ivashkin, V. T. et al. The prevalence of non-alcoholic fatty liver disease in patients of outpatient practice in the Russian Federation: The results of the study DIREG 2. Russ. J. Gastroenterol. Hepatol. Coloproctol. 25, 31\u201338 (2015).","journal-title":"Russ. J. Gastroenterol. Hepatol. Coloproctol."},{"key":"12004_CR29","first-page":"59","volume":"88","author":"AV Tkachev","year":"2016","unstructured":"Tkachev, A. V. et al. Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study. Ter. Arkh. 88, 59\u201366 (2016).","journal-title":"Ter. Arkh."},{"key":"12004_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.12691\/ajcmr-3-2-3","volume":"3","author":"OM Drapkina","year":"2015","unstructured":"Drapkina, O. M., Evsyutina, Y. & Ivashkin, V. Prevalence of non-alcoholic fatty liver disease in the Russian Federation: The open, multicenter, prospective study, DIREG 1. Am. J. Clin. Med. Res. 3, 31\u201336 (2015).","journal-title":"Am. J. Clin. Med. Res."},{"key":"12004_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12882-021-02483-y","volume":"22","author":"C Missikpode","year":"2021","unstructured":"Missikpode, C. et al. Association of elevated serum aminotransferase levels with chronic kidney disease measures: Hispanic community health study\/study of latinos. BMC Nephrol. 22, 302 (2021).","journal-title":"BMC Nephrol."},{"key":"12004_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.14744\/hf.2020.0006","volume":"1","author":"E Kaya","year":"2020","unstructured":"Kaya, E., Bakir, A., Eren, F. & Yilmaz, Y. The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases. Hepatol. Forum 1, 8\u201313 (2020).","journal-title":"Hepatol. Forum"},{"key":"12004_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33 (2006).","journal-title":"BMC Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12004-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12004-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12004-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:43:38Z","timestamp":1669344218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12004-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12004"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12004-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"21 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7842"}}